{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T23:22:42Z","timestamp":1778714562109,"version":"3.51.4"},"reference-count":36,"publisher":"Elsevier BV","issue":"1-2","license":[{"start":{"date-parts":[[2014,11,1]],"date-time":"2014-11-01T00:00:00Z","timestamp":1414800000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2014,11,1]],"date-time":"2014-11-01T00:00:00Z","timestamp":1414800000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100004431","name":"European Commission","doi-asserted-by":"publisher","award":["242210"],"award-info":[{"award-number":["242210"]}],"id":[{"id":"10.13039\/100004431","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Greek NSRF","award":["380221"],"award-info":[{"award-number":["380221"]}]},{"name":"Greek NSRF","award":["1154"],"award-info":[{"award-number":["1154"]}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jni-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Neuroimmunology"],"published-print":{"date-parts":[[2014,11]]},"DOI":"10.1016\/j.jneuroim.2014.09.013","type":"journal-article","created":{"date-parts":[[2014,9,19]],"date-time":"2014-09-19T12:04:28Z","timestamp":1411128268000},"page":"150-158","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"title":["Expression of extracellular domains of muscle specific kinase (MuSK) and use as immunoadsorbents for the development of an antigen-specific therapy"],"prefix":"10.1016","volume":"276","author":[{"given":"Lamprini","family":"Skriapa","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paraskevi","family":"Zisimopoulou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nikolaos","family":"Trakas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eirini","family":"Grapsa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Socrates J.","family":"Tzartos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.jneuroim.2014.09.013_bb0005","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1212\/01.wnl.0000228225.23349.5d","article-title":"Anti-MuSK antibodies: correlation with myasthenia gravis severity","volume":"67","author":"Bartoccioni","year":"2006","journal-title":"Neurology"},{"issue":"4","key":"10.1016\/j.jneuroim.2014.09.013_bb0010","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1046\/j.1526-0968.2000.004004275.x","article-title":"Therapeutic apheresis in myasthenia gravis","volume":"4","author":"Batocchi","year":"2000","journal-title":"Ther. Apher."},{"issue":"5795","key":"10.1016\/j.jneuroim.2014.09.013_bb0015","doi-asserted-by":"crossref","first-page":"1975","DOI":"10.1126\/science.1130837","article-title":"Dok-7 mutations underlie a neuromuscular junction synaptopathy","volume":"313","author":"Beeson","year":"2006","journal-title":"Science"},{"issue":"5","key":"10.1016\/j.jneuroim.2014.09.013_bb0020","doi-asserted-by":"crossref","first-page":"a009167","DOI":"10.1101\/cshperspect.a009167","article-title":"The role of MuSK in synapse formation and neuromuscular disease","volume":"5","author":"Burden","year":"2013","journal-title":"Cold Spring Harb. Perspect. Biol."},{"issue":"3","key":"10.1016\/j.jneuroim.2014.09.013_bb0025","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1161\/HYPERTENSIONAHA.109.148049","article-title":"Valsartan protects pancreatic islets and adipose tissue from the inflammatory and metabolic consequences of a high-fat diet in mice","volume":"55","author":"Cole","year":"2010","journal-title":"Hypertension"},{"issue":"4","key":"10.1016\/j.jneuroim.2014.09.013_bb0030","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1016\/S0092-8674(00)81251-9","article-title":"The receptor tyrosine kinase MuSK is required for neuromuscular junction formation in vivo","volume":"85","author":"DeChiara","year":"1996","journal-title":"Cell"},{"issue":"Pt 10","key":"10.1016\/j.jneuroim.2014.09.013_bb0035","doi-asserted-by":"crossref","first-page":"2304","DOI":"10.1093\/brain\/awg223","article-title":"Clinical correlates with anti-MuSK antibodies in generalized seronegative myasthenia gravis","volume":"126","author":"Evoli","year":"2003","journal-title":"Brain"},{"issue":"6","key":"10.1016\/j.jneuroim.2014.09.013_bb0040","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1002\/ana.410410615","article-title":"Clinical trial of plasma exchange and high-dose intravenous immunoglobulin in myasthenia gravis. Myasthenia Gravis Clinical Study Group","volume":"41","author":"Gajdos","year":"1997","journal-title":"Ann. Neurol."},{"issue":"3","key":"10.1016\/j.jneuroim.2014.09.013_bb0045","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/j.biocel.2010.10.008","article-title":"Muscle specific kinase: organiser of synaptic membrane domains","volume":"43","author":"Ghazanfari","year":"2011","journal-title":"Int. J. Biochem. Cell Biol."},{"key":"10.1016\/j.jneuroim.2014.09.013_bb0050","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1042\/bj0890114","article-title":"The preparation of I-131-labelled human growth hormone of high specific radioactivity","volume":"89","author":"Greenwood","year":"1963","journal-title":"Biochem. J."},{"issue":"3","key":"10.1016\/j.jneuroim.2014.09.013_bb0055","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1038\/85520","article-title":"Auto-antibodies to the receptor tyrosine kinase MuSK in patients with myasthenia gravis without acetylcholine receptor antibodies","volume":"7","author":"Hoch","year":"2001","journal-title":"Nat. Med."},{"issue":"51","key":"10.1016\/j.jneuroim.2014.09.013_bb0060","doi-asserted-by":"crossref","first-page":"20783","DOI":"10.1073\/pnas.1313944110","article-title":"MuSK IgG4 autoantibodies cause myasthenia gravis by inhibiting binding between MuSK and Lrp4","volume":"110","author":"Huijbers","year":"2013","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"Pt 4","key":"10.1016\/j.jneuroim.2014.09.013_bb0065","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1093\/brain\/aws025","article-title":"Muscle-specific kinase myasthenia gravis IgG4 autoantibodies cause severe neuromuscular junction dysfunction in mice","volume":"135","author":"Klooster","year":"2012","journal-title":"Brain"},{"issue":"1\u20132","key":"10.1016\/j.jneuroim.2014.09.013_bb0070","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.jneuroim.2007.07.018","article-title":"Extracellular domains of the beta, gamma and epsilon subunits of the human acetylcholine receptor as immunoadsorbents for myasthenic autoantibodies: a combination of immunoadsorbents results in increased efficiency","volume":"190","author":"Kostelidou","year":"2007","journal-title":"J. Neuroimmunol."},{"issue":"2","key":"10.1016\/j.jneuroim.2014.09.013_bb0075","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/S0955-3886(98)00022-8","article-title":"Plasmapheresis in myasthenia gravis. A survey","volume":"19","author":"Kuks","year":"1998","journal-title":"Transfus. Sci."},{"key":"10.1016\/j.jneuroim.2014.09.013_bb0080","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1111\/j.1749-6632.2012.06788.x","article-title":"Antigen-specific apheresis of autoantibodies in myasthenia gravis","volume":"1275","author":"Lazaridis","year":"2012","journal-title":"Ann. N. Y. Acad. Sci."},{"issue":"4","key":"10.1016\/j.jneuroim.2014.09.013_bb0085","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1002\/ana.20061","article-title":"Detection and characterization of MuSK antibodies in seronegative myasthenia gravis","volume":"55","author":"McConville","year":"2004","journal-title":"Ann. Neurol."},{"issue":"5","key":"10.1016\/j.jneuroim.2014.09.013_bb0090","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1016\/S1474-4422(09)70063-8","article-title":"Autoimmune myasthenia gravis: emerging clinical and biological heterogeneity","volume":"8","author":"Meriggioli","year":"2009","journal-title":"Lancet Neurol."},{"issue":"1\u20132","key":"10.1016\/j.jneuroim.2014.09.013_bb0095","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.jneuroim.2012.02.010","article-title":"3,4-Diaminopyridine improves neuromuscular transmission in a MuSK antibody-induced mouse model of myasthenia gravis","volume":"245","author":"Mori","year":"2012","journal-title":"J. Neuroimmunol."},{"issue":"Pt 6","key":"10.1016\/j.jneuroim.2014.09.013_bb0100","doi-asserted-by":"crossref","first-page":"1497","DOI":"10.1093\/brain\/awm068","article-title":"Phenotypical spectrum of DOK7 mutations in congenital myasthenic syndromes","volume":"130","author":"Muller","year":"2007","journal-title":"Brain"},{"issue":"1\u20132","key":"10.1016\/j.jneuroim.2014.09.013_bb0105","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.jneuroim.2004.10.002","article-title":"Specific immunoadsorption of the autoantibodies from myasthenic patients using the extracellular domain of the human muscle acetylcholine receptor alpha-subunit. Development of an antigen-specific therapeutic strategy","volume":"159","author":"Psaridi-Linardaki","year":"2005","journal-title":"J. Neuroimmunol."},{"issue":"2","key":"10.1016\/j.jneuroim.2014.09.013_bb0110","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.expneurol.2011.04.018","article-title":"Muscle-selective synaptic disassembly and reorganization in MuSK antibody positive MG mice","volume":"230","author":"Punga","year":"2011","journal-title":"Exp. Neurol."},{"issue":"6","key":"10.1016\/j.jneuroim.2014.09.013_bb0115","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1510\/icvts.2007.170894","article-title":"Surgical outcome in thymic tumors with myasthenia gravis after plasmapheresis\u2014a comparative study","volume":"7","author":"Sarkar","year":"2008","journal-title":"Interact. Cardiovasc. Thorac. Surg."},{"issue":"1","key":"10.1016\/j.jneuroim.2014.09.013_bb0120","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1002\/ana.21408","article-title":"Dok-7 myasthenia: phenotypic and molecular genetic studies in 16 patients","volume":"64","author":"Selcen","year":"2008","journal-title":"Ann. Neurol."},{"issue":"1","key":"10.1016\/j.jneuroim.2014.09.013_bb0125","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jmb.2009.07.091","article-title":"Crystal structure of the frizzled-like cysteine-rich domain of the receptor tyrosine kinase MuSK","volume":"393","author":"Stiegler","year":"2009","journal-title":"J. Mol. Biol."},{"issue":"3","key":"10.1016\/j.jneuroim.2014.09.013_bb0130","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1002\/jca.20129","article-title":"Guidelines on the use of therapeutic apheresis in clinical practice: evidence-based approach from the Apheresis Applications Committee of the American Society for Apheresis","volume":"22","author":"Szczepiorkowski","year":"2007","journal-title":"J. Clin. Apher."},{"issue":"3","key":"10.1016\/j.jneuroim.2014.09.013_bb0135","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1056\/NEJM197701202960301","article-title":"Myasthenia gravis. Study of humoral immune mechanisms by passive transfer to mice","volume":"296","author":"Toyka","year":"1977","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jneuroim.2014.09.013_bb0140","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.jneuroim.2011.09.007","article-title":"Development of a highly sensitive diagnostic assay for muscle-specific tyrosine kinase (MuSK) autoantibodies in myasthenia gravis","volume":"240\u2013241","author":"Trakas","year":"2011","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.jneuroim.2014.09.013_bb0145","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1196\/annals.1405.017","article-title":"Antigen-specific apheresis of pathogenic autoantibodies from myasthenia gravis sera","volume":"1132","author":"Tzartos","year":"2008","journal-title":"Ann. N. Y. Acad. Sci."},{"issue":"5844","key":"10.1016\/j.jneuroim.2014.09.013_bb0150","doi-asserted-by":"crossref","first-page":"1554","DOI":"10.1126\/science.1144603","article-title":"Anti-inflammatory activity of human IgG4 antibodies by dynamic Fab arm exchange","volume":"317","author":"van der Neut Kolfschoten","year":"2007","journal-title":"Science"},{"issue":"2","key":"10.1016\/j.jneuroim.2014.09.013_bb0155","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1016\/j.expneurol.2012.01.025","article-title":"Passive and active immunization models of MuSK-Ab positive myasthenia: electrophysiological evidence for pre and postsynaptic defects","volume":"234","author":"Viegas","year":"2012","journal-title":"Exp. Neurol."},{"issue":"1\u20132","key":"10.1016\/j.jneuroim.2014.09.013_bb0160","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1385\/JMN:30:1:223","article-title":"MuSK signaling at the neuromuscular junction","volume":"30","author":"Wang","year":"2006","journal-title":"J. Mol. Neurosci."},{"issue":"9","key":"10.1016\/j.jneuroim.2014.09.013_bb0165","doi-asserted-by":"crossref","first-page":"4585","DOI":"10.1073\/pnas.080061997","article-title":"The in vitro and in vivo phosphotyrosine map of activated MuSK","volume":"97","author":"Watty","year":"2000","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.jneuroim.2014.09.013_bb0175","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.jneuroim.2008.06.020","article-title":"Towards antigen-specific apheresis of pathogenic autoantibodies as a further step in the treatment of myasthenia gravis by plasmapheresis","volume":"201\u2013202","author":"Zisimopoulou","year":"2008","journal-title":"J. Neuroimmunol."},{"issue":"1\u20132","key":"10.1016\/j.jneuroim.2014.09.013_bb0180","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.jneuroim.2008.06.002","article-title":"Antigen-specific apheresis of human anti-acetylcholine receptor autoantibodies from myasthenia gravis patients' sera using Escherichia coli-expressed receptor domains","volume":"200","author":"Zisimopoulou","year":"2008","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.jneuroim.2014.09.013_bb0170","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.jaut.2013.12.004","article-title":"A comprehensive analysis of the epidemiology and clinical characteristics of anti-LRP4 in myasthenia gravis","volume":"52","author":"Zisimopoulou","year":"2014","journal-title":"J. Autoimmun."}],"container-title":["Journal of Neuroimmunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S016557281400890X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S016557281400890X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,28]],"date-time":"2025-09-28T08:24:06Z","timestamp":1759047846000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S016557281400890X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,11]]},"references-count":36,"journal-issue":{"issue":"1-2","published-print":{"date-parts":[[2014,11]]}},"alternative-id":["S016557281400890X"],"URL":"https:\/\/doi.org\/10.1016\/j.jneuroim.2014.09.013","relation":{},"ISSN":["0165-5728"],"issn-type":[{"value":"0165-5728","type":"print"}],"subject":[],"published":{"date-parts":[[2014,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Expression of extracellular domains of muscle specific kinase (MuSK) and use as immunoadsorbents for the development of an antigen-specific therapy","name":"articletitle","label":"Article Title"},{"value":"Journal of Neuroimmunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jneuroim.2014.09.013","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}